| --- |
| license: cc-by-4.0 |
| pretty_name: Global Drug Development & Classification |
| tags: |
| - pharmacology |
| - drug-development |
| - nme |
| - first-in-class |
| task_categories: |
| - tabular-classification |
| size_categories: |
| - 1K<n<10K |
| --- |
| |
| 💊 **Dataset Summary** |
|
|
| A curated drug intelligence database covering 2,175 therapeutic compounds with multilingual entity resolution. Each record links a drug to its biological targets, disease indications, development status, and approval history. |
|
|
| **🚀 Key Features** |
|
|
| - **Multilingual Entities:** Drug names, aliases, targets, and disease indications are all provided in both Chinese and English. |
| - **Target & Indication Mapping:** Structured `target` and `disease` arrays enable drug-target-disease network construction. |
| - **Development Status:** `global_highest_dev_status` and `first_approved_date` track the regulatory lifecycle. |
| - **Drug Typing:** `drug_type` classifies modality (e.g., Fc fusion protein, Biosimilar, small molecule). |
|
|
| **💻 Quick Start** |
|
|
| ```python |
| from datasets import load_dataset |
| |
| dataset = load_dataset("your-org/drug-intelligence", split="train") |
| record = dataset[0] |
| en_name = next(n["name"] for n in record["drug_name"] if n["lang"] == "EN") |
| print(en_name) |
| # Output: 'Aflibercept Biosimilar(Zakłady Farmaceutyczne Polpharma SA)' |
| print(record["global_highest_dev_status"]) |
| # Output: 'Approved' |
| print(record["drug_type"]) |
| # Output: ['Fc fusion protein', 'Biosimilar'] |
| ``` |
|
|
|
|
| ## 🔗 Resources |
| - **Developer Portal**: [open.patsnap.com](https://open.patsnap.com) |
| - **PatSnap Life Sciences**: [patsnap.com/solutions/life-sciences](https://www.patsnap.com/solutions/life-sciences/) |
| - **GitHub**: [github.com/patsnap](https://github.com/patsnap) |
